litlas
Log inCreate account

James E. Montie

Active 1977–2024

98
Papers
24,917
Citations
80
h-index
96
i10-index

Citations

Citations per year for James E. Montie1931: 1 citations1967: 1 citations1978: 1 citations1981: 1 citations1982: 1 citations1983: 3 citations1984: 1 citations1986: 5 citations1987: 2 citations1988: 4 citations1989: 6 citations1990: 9 citations1991: 13 citations1992: 11 citations1993: 20 citations1994: 19 citations1995: 31 citations1996: 16 citations1997: 24 citations1998: 27 citations1999: 33 citations2000: 52 citations2001: 66 citations2002: 83 citations2003: 99 citations2004: 82 citations2005: 108 citations2006: 184 citations2007: 233 citations2008: 290 citations2009: 304 citations2010: 263 citations2011: 246 citations2012: 263 citations2013: 248 citations2014: 191 citations2015: 153 citations2016: 140 citations2017: 134 citations2018: 113 citations2019: 351 citations2020: 381 citations2021: 309 citations2022: 205 citations2023: 126 citations2024: 177 citations2025: 88 citations2026: 6 citations1932–1966: no citations, so these years are not shown1968–1977: no citations, so these years are not shown1979–1980: no citations, so these years are not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,646 citing papers, 37% of this breakdownUnited Kingdom: 496 citing papers, 6.9% of this breakdownChina: 395 citing papers, 5.5% of this breakdownCanada: 379 citing papers, 5.3% of this breakdownGermany: 373 citing papers, 5.2% of this breakdownItaly: 289 citing papers, 4% of this breakdownNetherlands: 213 citing papers, 3% of this breakdownFrance: 202 citing papers, 2.8% of this breakdownJapan: 175 citing papers, 2.5% of this breakdownSpain: 171 citing papers, 2.4% of this breakdownAustralia: 170 citing papers, 2.4% of this breakdownSweden: 170 citing papers, 2.4% of this breakdown
0%37%Other 20.6%

Institutions

Fields

  • Medicine70.4%
  • Biochemistry, Genetics and Molecular Biology22.4%
  • Immunology and Microbiology2.4%
  • Computer Science1%
  • Agricultural and Biological Sciences0.8%
  • Health Professions0.4%
  • Other2.6%

Topics

  • Prostate Cancer Treatment and Research10.3%
  • Prostate Cancer Diagnosis and Treatment8.1%
  • Bladder and Urothelial Cancer Treatments6.9%
  • Urinary and Genital Oncology Studies3.9%
  • Cancer Genomics and Diagnostics2%
  • Cancer survivorship and care1.9%
  • Other66.9%

Coauthors

All papers

Open in search
  1. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

    Authors: Scott A. Tomlins, Daniel R. Rhodes, Sven Perner, Saravana M. Dhanasekaran, Rohit Mehra, Xiao Sun, Sooryanarayana Varambally, Xuhong Cao, Joëlle Tchinda, Rainer Kuefer, Charles Lee, James E. Montie, Rajal B. Shah, Kenneth J. Pienta, Mark A. Rubin, Arul M. Chinnaiyan - Science 2005 cited by 3,865

  2. MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

    Authors: Donald L. Lamm, Brent A. Blumenstein, John D. Crissman, James E. Montie, James E. Gottesman, Bruce A. Lowe, Michael F. Sarosdy, ROBERT D. BOHL, H. Barton Grossman, Thomas Beck, Joseph T. Leimert, E. David Crawford - The Journal of Urology 2000 cited by 1,316

  3. Germline Mutations in HOXB13 and Prostate-Cancer Risk

    Authors: Charles M. Ewing, Anna M. Ray, Ethan M. Lange, Kimberly A. Zuhlke, Christiane M. Robbins, Waibhav Tembe, Kathleen E. Wiley, Sarah D. Isaacs, Dorhyun Johng, Yunfei Wang, Chris Bizon, Guifang Yan, Marta Gielzak, Alan W. Partin, Vijayalakshmi Shanmugam, Tyler Izatt, Shripad Sinari, David W. Craig, Shusen Zheng, Patrick C. Walsh, James E. Montie, Jianfeng Xu, John D. Carpten, William B. Isaacs, Kathleen A. Cooney - New England Journal of Medicine 2012 cited by 670

  4. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

    Authors: Scott A. Tomlins, Bharathi Laxman, Saravana M. Dhanasekaran, Beth E. Helgeson, Xuhong Cao, David S. Morris, Anjana Menon, Xiaojun Jing, Qi Cao, Bo Han, Jindan Yu, Lei Wang, James E. Montie, Mark A. Rubin, Kenneth J. Pienta, Diane Roulston, Rajal B. Shah, Sooryanarayana Varambally, Rohit Mehra, Arul M. Chinnaiyan - Nature 2007 cited by 848

  5. A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

    Authors: Donald L. Lamm, Brent A. Blumenstein, E. David Crawford, James E. Montie, Peter T. Scardino, H. Barton Grossman, Thomas H. Stanisic, Joseph A. Smith, Jerry Sullivan, Michael F. Sarosdy, John D. Crissman, Charles A. Coltman - New England Journal of Medicine 1991 cited by 617

  6. Bladder Cancer in 2010: How Far have We Come?

    Authors: Bruce L. Jacobs, C. T. Lee, James E. Montie - CA A Cancer Journal for Clinicians 2010 cited by 346

  7. Randomized clinical trial of a family intervention for prostate cancer patients and their spouses

    Authors: Laurel Northouse, Darlene Mood, Ann Schafenacker, James E. Montie, Howard M. Sandler, Jeffrey D. Forman, Maha Hussain, Kenneth J. Pienta, David C. Smith, Trace Kershaw - Cancer 2007 cited by 339

  8. A common variant associated with prostate cancer in European and African populations

    Authors: Laufey T. Ámundadóttir, Patrick Sulem, Jūlı́us Guðmundsson, Agnar Helgason, Adam Baker, Bjarni A. Agnarsson, Ásgeir Sigurðsson, Kristrún R. Benediktsdóttir, Jean‐Baptiste Cazier, Jesús Sainz, Margret Jakobsdottir, Jelena Kostic, Droplaug N. Magnúsdóttir, Shyamali Ghosh, Kari Agnarsson, Birgitta Birgisdottir, Louise le Roux, Aðalheiður Ólafsdóttir, Thórarinn Blöndal, Margrét B. Andrésdóttir, Olafia S. Gretarsdottir, Jón Þór Bergþorsson, Daníel F. Guðbjartsson, Arnaldur Gylfason, Guðmar Þorleifsson, Andrei Manolescu, Kristleifur Kristjánsson, Guðmundur Geirsson, Helgi J. Ísaksson, Julie A. Douglas, Jan-Erik Johansson, Katarina Bälter, Fredrik Wiklund, James E. Montie, Xiaoying Yu, Brian K. Suarez, Carole Ober, Kathleen A. Cooney, Henrik Grönberg, William J. Catàlona, Guðmundur Einarsson, Rósa B. Barkardóttir, Jeffrey R. Gulcher, Augustine Kong, Unnur Þorsteinsdóttir, Kāri Stefánsson - Nature Genetics 2006 cited by 792

  9. Cystectomy Delay More Than 3 Months From Initial Bladder Cancer Diagnosis Results in Decreased Disease Specific and Overall Survival

    Authors: Cheryl T. Lee, Rabii Madii, Stephanie Daignault, Rodney L. Dunn, Yingxi Zhang, James E. Montie, David P. Wood - The Journal of Urology 2006 cited by 190

  10. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital

    Authors: Rajal B. Shah, Jeffrey S. Montgomery, James E. Montie, Lakshmi P. Kunju - Urologic Oncology Seminars and Original Investigations 2012 cited by 172

  11. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

    Authors: Scott A. Tomlins, Daniel R. Rhodes, Sven Perner, Saravana M. Dhanasekaran, Rohit Mehra, Xiaodong Sun, Sooryanarayana Varambally, Xuhong Cao, Joëlle Tchinda, Rainer Kuefer, C. Lee, James E. Montie, Rajal B. Shah, Kenneth J. Pienta, Mark A. Rubin, Arul M. Chinnaiyan - Science 2005 cited by 3,887

  12. JAGGED1 Expression Is Associated with Prostate Cancer Metastasis and Recurrence

    Authors: Sandro Santagata, Francesca Demichelis, Alberto Riva, Sooryanarayana Varambally, Matthias D. Hofer, Jeffery L. Kutok, Robert Kim, Jeffery Tang, James E. Montie, Arul M. Chinnaiyan, Mark A. Rubin, Jon C. Aster - Cancer Research 2004 cited by 341

  13. Heterogeneity of TMPRSS2 Gene Rearrangements in Multifocal Prostate Adenocarcinoma: Molecular Evidence for an Independent Group of Diseases

    Authors: Rohit Mehra, Bo Han, Scott A. Tomlins, Lei Wang, Anjana Menon, Matthew J. Wasco, Ronglai Shen, James E. Montie, Arul M. Chinnaiyan, Rajal B. Shah - Cancer Research 2007 cited by 217

  14. Delays in diagnosis and bladder cancer mortality

    Authors: Brent K. Hollenbeck, Rodney L. Dunn, Zaojun Ye, John M. Hollingsworth, Ted A. Skolarus, Simon P. Kim, James E. Montie, Cheryl T. Lee, David P. Wood, David C. Miller - Cancer 2010 cited by 163

  15. The Causal Role of Cigarette Smoking in Bladder Cancer Initiation and Progression, and the Role of Urologists in Smoking Cessation

    Authors: Seth A. Strope, James E. Montie - The Journal of Urology 2008 cited by 120

  16. Quality of Care for Renal Masses: The Michigan Urological Surgery Improvement Collaborative—Kidney Mass: Identifying & Defining Necessary Evaluation & Therapy (MUSIC-KIDNEY)

    Authors: Sabrina L. Noyes, Tae Il Kim, Anna Johnson, Susan Linsell, Ji Qi, T Moldovan, Amit Patel, Khurshid R. Ghani, James E. Montie, Craig Rogers, Brian R. Lane - Urology Practice 2020 cited by 20

  17. Development and Validation of Dynamic Multivariate Prediction Models of Sexual Function Recovery in Patients with Prostate Cancer Undergoing Radical Prostatectomy: Results from the MUSIC Statewide Collaborative

    Authors: Nnenaya A. Mmonu, Adharsh Murali, Daniela Wittmann, Brian T. Denton, Rodney L. Dunn, James E. Montie, James O. Peabody, David C. Miller, Karandeep Singh - European Urology Open Science 2022 cited by 15

  18. Autoantibody Signatures in Prostate Cancer

    Authors: Xiaoju Wang, Jianjun Yu, Arun Sreekumar, Sooryanarayana Varambally, Ronglai Shen, Donald Giacherio, Rohit Mehra, James E. Montie, Kenneth J. Pienta, Martin G. Sanda, Philip W. Kantoff, Mark A. Rubin, John T. Wei, Debashis Ghosh, Arul M. Chinnaiyan - New England Journal of Medicine 2005 cited by 583

  19. Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy

    Authors: David C. Miller, Martin G. Sanda, Rodney L. Dunn, James E. Montie, Hector Pimentel, Howard M. Sandler, William P. McLaughlin, John T. Wei - Journal of Clinical Oncology 2005 cited by 382

  20. Living With Prostate Cancer: Patients' and Spouses' Psychosocial Status and Quality of Life

    Authors: Laurel Northouse, Darlene Mood, James E. Montie, Howard M. Sandler, Jeffrey D. Forman, Maha Hussain, Kenneth J. Pienta, David C. Smith, Martin G. Sanda, Trace Kershaw - Journal of Clinical Oncology 2007 cited by 218

  21. Contemporary Use of Initial Active Surveillance Among Men in Michigan with Low-risk Prostate Cancer

    Authors: Paul R. Womble, James E. Montie, Zaojun Ye, Susan Linsell, Brian R. Lane, David C. Miller - European Urology 2014 cited by 207

  22. Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience

    Authors: Kevin Ginsburg, Michael L. Cher, James E. Montie - The Journal of Urology 2020 cited by 19

  23. Validity of the Patient-Reported Outcome Measurement Information System (PROMIS) Sexual Interest and Satisfaction Measures in Men Following Radical Prostatectomy

    Authors: Nnenaya A. Mmonu, Daniela Wittmann, Nicholas R. Boileau, Rodney L. Dunn, James E. Montie, Tae Kim, David C. Miller, James O. Peabody, Noelle E. Carlozzi, for the Michigan Urological Surgery Improvement Collaborative - Journal of Clinical Oncology 2019 cited by 18

  24. OR Practice-Data Analytics for Optimal Detection of Metastatic Prostate Cancer

    Authors: Selin Merdan, Christine Barnett, Brian T. Denton, James E. Montie, David C. Miller - Operations Research, Oper. Res. 2021 cited by 10